Identification Of The Potential Targets Of Mir-143-3p In Colorectal Cancer Through Bioinformatics Analysis
Li-Hua Yang,Zu-Cheng Xie,Rong-Quan He,Sheng-Sheng Zhou,Rong-Mei Meng,Cai-Xia Feng,Jie-Mei Cen,Han-Lin Wang,Hai-Wei Liang,Zhi-Gang Peng,Jie Ma,Yu-Yan Pang,Gang Chen
2017-01-01
Abstract:Background: Colorectal cancer (CRC) is a malignant tumor with a high incidence and mortality worldwide. However, traditional treatments are not satisfactory. Thus, novel therapeutic strategies are urgently required. Recently, microRNAs have been proven to be involved in various biological processes, such as cell differentiation, cell proliferation, apoptosis and tumorigenesis, which could have potential therapeutic value in CRC. Methods: In this study, we aimed to identify the target genes and potential molecular mechanism of miR-143-3p. GEO microarray GSE33420, which was generated using 2 colon cell lines, and 12 prediction databases were combined to seek the overlapping target genes of miR-143-3p in CRC. GO enrichment analysis and the KEGG pathway were respectively performed to explore the prospective pathways of miR-143-3p in CRC. The overlapping genes were further uploaded to the STRING 10.0 database for protein-protein interaction network (PPI) construction. All these work was conducted through computational database resources. Results: Forty-three overlapping candidate target genes of miR-143-3p in CRC were achieved through the GEO microarray and prediction databases. Nine genes (MAPK1, PTPN23, ERBB3, PKN2, KLF5, YARS, ETV6, PDPR and YWHAB) were shown as hub genes in the PPI network. Conclusions: In the present study, among the nine hub genes we discovered, KLF5 has been reported as a target gene of miR-143-3p in CRC. MAPK1, ERBB3, YWHAB, KLF5 and ETV6 have great potential to serve as key target genes of miR-143-3p, likely exerting a therapeutic effect in the treatment of CRC. Regarding PTPN23, PKN2, YARS and PDPR, research to support their roles in CRC is lacking. Nevertheless, further studies are required to confirm the results.